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Recent studies have proposed that bone mar-
row hematopoietic stem cells (HSCs) are main-
tained via N-cadherin-mediated homophilic ad-
hesion with osteoblasts. However, there is not
yet any evidence that N-cadherin-expressing
cells have HSC activity or that osteoblasts are
required for HSCmaintenance. We were unable
to detect N-cadherin expression in highly puri-
fied HSCs by polymerase chain reaction, by us-
ing commercial anti-N-cadherin antibodies, or
by b-galactosidase staining of N-cadherin
gene trap mice. Only N-cadherin-negative
bonemarrow cells exhibitedHSCactivity in irra-
diated mice. Finally, biglycan-deficient mice
had significant reductions in trabecular bone
and osteoblasts but showed no defects in
hematopoiesis, HSC frequency, or function.
Thus, reductions in osteoblasts do not neces-
sarily lead to reductions in HSCs. Most bone
marrow HSCs in wild-type and biglycan-defi-
cient mice localized to sinusoids, and few local-
izedwithin five cell diameters of the endosteum.
These results question whether significant
numbers of HSCs depend on N-cadherin-medi-
ated adhesion to osteoblasts.
INTRODUCTION
Hematopoietic stem cells (HSCs) persist throughout adult
life in the bone marrow, where they continuously produce
new blood cells. HSC maintenance is hypothesized to de-
pend on the localization of HSCs to specialized microen-
vironments (niches) within the bone marrow (Adams and
Scadden, 2006; Moore and Lemischka, 2006; Wilson
and Trumpp, 2006). The identification of these niches
has been a major goal of the field.204 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier IncOsteoblasts are capable of influencing bone marrow
HSC frequency. Osteoblasts secrete factors that regulate
HSC maintenance and function (Taichman et al., 1996;
Arai et al., 2004; Nilsson et al., 2005; Stier et al., 2005;
Zhu et al., 2007), and genetic manipulations that increase
osteoblast numbers in mice also increase the number of
HSCs (Calvi et al., 2003; Zhang et al., 2003). Osteoclast
function (Kollet et al., 2006), and the high levels of calcium
thought to be generated from bone resorption (Adams
et al., 2006), also regulates HSC migration and mainte-
nance. These observations indicate that osteoblasts and
the endosteum (the interface of bone and marrow where
osteoblasts and osteoclasts localize) regulate HSC func-
tion and raise the question of whether HSCs localize to
the endosteum itself or whether they are influenced at
a distance (directly or indirectly) by extracellular factors
that diffuse from the endosteum.
HSCs have been suggested to reside in direct contact
with osteoblasts via homophilic adhesion between N-cad-
herin-expressing HSCs and N-cadherin-expressing oste-
oblasts (Zhang et al., 2003; Wilson et al., 2004). Ten per-
cent of mouse c-kit+lineageSca-1+ cells stained with
a commercial anti-N-cadherin antibody, and BrdU label-
retaining, N-cadherin+ bone marrow cells were observed
in contact with osteoblasts (Zhang et al., 2003). However,
it has not yet been tested whether these N-cadherin+ cells
are HSCs or other cells that express similar markers. It
also has not yet been tested whether N-cadherin is genet-
ically required for HSC maintenance.
Two laboratories have published microarray analyses of
highly purified HSCs that include data on N-cadherin
(Ivanova et al., 2002; Kiel et al., 2005). Neither detected
N-cadherinexpression by HSCs, yet both detectedN-cad-
herin expression by neural stem cells and embryonic stem
cells using the same microarray platform (Ivanova et al.,
2002; Molofsky et al., 2003). These studies raise the ques-
tion of whether N-cadherin is expressed by HSCs.
Apart from the role of N-cadherin is the more general
question of where HSCs reside in bone marrow. We sys-
tematically examined the localization of HSCs in the
bone marrow using SLAM family receptors and found
that most HSCs reside on the surface of sinusoidal blood.
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and enhance the identification of HSCs as 45% of single
CD150+CD48CD41 bone marrow cells give long-term
multilineage reconstitution in irradiated mice (Kiel et al.,
2005). Almost all of these cells are c-kit+, Sca-1+, and lin-
eage, so these markers can be used in conjunction with
SLAM markers to purify the same population of HSCs,
though they add little additional purity (Kiel et al., 2005).
This ‘‘SLAM code’’ for HSCs has held up in every context
of definitive hematopoiesis that we have examined (Kim
et al., 2006; Yilmaz et al., 2006a). In our analysis, 60% of
HSCs localized to sinusoids in the bone marrow, while
14% of HSCs localized to the endosteum (Kiel et al.,
2005). Remaining HSCs were in other locations. This
raised the possibility that most HSCs reside in sinusoidal
vascular niches—a possibility that was further supported
by the recent discovery that CXCL12-expressing reticular
cells also reside adjacent to these sinusoids (Sugiyama
et al., 2006).
It is unclear whether osteoblasts are physiologically re-
quired for HSC maintenance. To test this, it would be nec-
essary to deplete osteoblasts in vivo to test whether they
are not only sufficient to increase HSC numbers (Calvi
et al., 2003; Zhang et al., 2003) but also necessary for
HSC maintenance. This has been done by ablating osteo-
blasts from adult Col1a1-TK mice (Visnjic et al., 2004; Zhu
et al., 2007). The authors did not observe an acute loss of
HSCs. Rather, they observed an acute loss of differentiat-
ing cells, particularly B lineage progenitors. The frequency
of c-kit+lineageSca-1+ cells in bone marrow actually in-
creased over time after osteoblast ablation (Visnjic et al.,
2004; Zhu et al., 2007). HSCs depletion was not observed
until weeks later, after bone marrow cellularity was se-
verely reduced. This raises the question of whether
HSCs are slowly lost as a direct consequence of osteo-
blast ablation or whether HSCs do not depend directly
on osteoblasts but rather are ultimately depleted as a con-
sequence of the loss of other cells. To resolve this ques-
tion, the ideal approach would be to chronically deplete
osteoblasts in vivo without inducing acute hematopoietic
failure to test whether this depletes HSCs.
In this study, we have been unable to detect N-cadherin
expression in highly purified HSCs by a variety of pheno-
typic and functional approaches. Thus, N-cadherin is un-
likely to mediate homophilic adhesion between HSCs and
osteoblasts. Reductions in trabecular bone and osteo-
blasts in biglycan-deficient mice had no effect on hemato-
poiesis, HSC frequency, or HSC function. We also con-
firmed that most HSCs localize to sinusoids within the
bone marrow and that almost all HSCs are found within
five cell diameters of a sinusoid. In contrast, only 8%–
21% of HSCs were within five cell diameters of endos-
teum. These data suggest that most HSCs do not acutely
depend on contact with osteoblasts for their maintenance,
though it remains possible that a subset of HSCs is main-
tained at or near the endosteum by mechanisms other
than N-cadherin-mediated adhesion. These results raise
the question of whether the endosteum influences HSC lo-
calization and maintenance directly, by affecting a subsetCeof HSCs that is present at the endosteum, or indirectly, by
the secretion of diffusible factors that influence the ability
of other cells to create niches for HSCs in other locations.
RESULTS
N-Cadherin IsNot Detectable in Highly PurifiedHSCs
We examined N-cadherin expression by a variety of ap-
proaches in highly purified HSCs. First, we tested whether
HSCs expressed N-cadherin at the mRNA level by at-
tempting to amplify N-cadherin from cDNA isolated from
highly purified CD150+CD48CD41c-kit+Sca-1+lineage
HSCs. CD150+CD48CD41c-kit+Sca-1+lineage cells
represented 0.0076% ± 0.0021% of bone marrow cells
in these experiments. This population contains all of the
HSC activity from C57BL mouse bone marrow, and 47%
of single cells within this population give long-term multi-
lineage reconstitution in irradiated mice (Kiel et al.,
2005). We were readily able to amplify N-cadherin from
neonatal forebrain cells, which are known to express N-
cadherin (Redies and Takeichi, 1993) (Figures 1A and
1B). However, we were never able to amplify N-cadherin
from aliquots of CD150+CD48CD41c-kit+Sca-1+line-
age HSCs (Figures 1A and 1B). We were also unable to
amplify N-cadherin from aliquots of c-kit+Sca-1+linea-
geFlk-2 HSCs (Figures 1A and 1B), which represented
0.021% ± 0.001% of bone marrow cells and which are
also highly enriched for HSCs (Christensen and
Weissman, 2001; Kiel et al., 2005). In contrast, we were
able to amplify similar amounts of hypoxanthine phos-
phoribosyltransferase (HPRT) from all of the samples
(Figure 1B). Thus, we were unable to detect N-cadherin
transcripts in highly purified HSCs.
To test N-cadherin expression at the protein level, we
stained highly purified HSCs with two commercially avail-
able anti-N-cadherin antibodies and examined the stain-
ing by flow cytometry. These antibodies included the YS
polyclonal anti-N-cadherin antibody that has been used
previously to stain bone marrow (Zhang et al., 2003;
Wilson et al., 2004), and the GC-4 monoclonal anti-N-cad-
herin antibody that has been used previously to character-
ize N-cadherin expression by epithelial progenitors
(Hayashi et al., 2006). Both antibodies were able to stain
neonatal forebrain cells by flow cytometry (Figure 1C). In
contrast, neither antibody showed any staining above
background on either CD150+CD48CD41c-kit+Sca-
1+lineage HSCs or c-kit+Sca-1+lineageFlk-2 HSCs
(Figure 1D). Thus, we were unable to detect N-cadherin
expression on the surface of highly purified HSCs using
commercially available antibodies.
If a subset of HSCs adheres to the endosteum, it is pos-
sible that these cells might be depleted within marrow
samples that are obtained by flushing the marrow cavity
with medium. To test whether this approach leaves behind
significant numbers of HSCs, we used a bone burr (a drill,
see the Experimental Procedures) to remove any cells
remaining in the flushed marrow cavity. Representative
images of sections through the marrow cavity from unma-
nipulated bone, flushed bone, and burred bone are shownll Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc. 205
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mRNA or Protein Expression by Highly
Purified HSCs
(A) N-cadherin could be readily amplified from
three independent samples of neonatal fore-
brain cells, but not CD150+CD48CD41c-
kit+Sca-1+lineage HSCs or c-kit+Sca-1+line-
ageFlk2 HSCs by quantitative PCR, despite
amplifying similar amounts of HPRT from the
same samples. Data show the amplification
of transcript against cycle number (left panel)
as well as the melting curve, demonstrating
specific amplification of HPRT in all samples
but N-cadherin only in forebrain samples.
These data are representative of three inde-
pendent experiments using four to five inde-
pendently sorted HSC aliquots. Two hundred
cell equivalents of cDNA were used per
reaction.
(B) PCR products were separated on a 2%
agarose gel that revealed a product of the ex-
pected size for N-cadherin only in forebrain
samples. Sequencing revealed that this prod-
uct was N-cadherin but that bands of other
sizes in other lanes were nonspecific products.
(C) Polyclonal (YS) and monoclonal (GC-4)
anti-N-cadherin antibodies were used to stain
neonatal forebrain cells. Staining was exam-
ined by flow cytometry relative to control cells
stained only with secondary antibodies.
(D) We could not detect N-cadherin staining
above background with either the YS or GC-4
antibodies on CD150+CD48CD41c-kit+Sca-
1+lineage HSCs or c-kit+Sca-1+lineage
Flk2 HSCs. These data are representative of
three to nine independent experiments.in Figures 2A–2C. The vast majority of bone marrow cells
were removed by simply flushing the bone marrow cavity:
we did not observe residual bone marrow cells on most
endosteal surfaces after flushing (Figure 2B). Nonethe-206 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc.less, there were some locations where residual bone mar-
row cells were present (Figure 2Bb). After scoring the end-
osteal surface with the bone burr, these residual cells were
effectively removed (Figure 2C). We did not detect any
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Hematopoietic Stem Cells Do Not Express N-CadherinFigure 2. Flushing with Medium Washes the Vast Majority of Bone Marrow Cells and HSCs out of the Bone Marrow Cavity
(A–C) Hematoxylin and eosin stained sections through undecalcified, gelatin-embedded femurs (A) or femurs that were ‘‘flushed’’ with medium to
remove marrow cells (B) or subsequently ‘‘burred’’ (drilling through the marrow cavity) to remove residual cells (C). Images show diaphysis sections
(a) and epiphysis (b) sections as well as higher magnification images (c) (scale bar is always 150 mm). Only 1.6% of bone marrow cells was retained
within the marrow cavity after flushing (arrowhead), and these residual cells were recovered by burring.
(D) The frequency of CD150+CD48CD41c-kit+Sca-1+lineage HSCs did not differ among bone marrow cells recovered by flushing versus burring
(p = 0.83, n = 3).
(E) Taken together, this means that 98.5% of HSCs were recovered by flushing the bone marrow cavity.
(F) When 300,000 cells from either the flushed or burred fractions of bone marrow were injected into irradiated mice in competitive reconstitution as-
says, seven of seven recipients of flushed marrow cells and four of six recipients of burred marrow cells became long-term multilineage reconstituted
by donor cells. There was no statistically significant difference in overall levels of donor cell reconstitution in these mice. Error bars represent SD.difference in overall viability or in the frequency of
CD150+CD48CD41c-kit+Sca-1+lineage HSCs in the
burred fraction of bone marrow cells as compared to theCflushed fraction of cells (Figure 2D). Moreover, the total
number of bone marrow cells isolated in the burred frac-
tion was only 1.6% of the bone marrow cells recoveredell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc. 207
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Expressed by HSCs Isolated fromN-cad-
herinlacZ/+ Gene Trap Mice
c-kit+Sca-1+lineageFlk-2 HSCs or
CD150+CD48CD41c-kit+Sca-1+lineageHSCs
were isolated from Rosa mice (A), N-
cadherinlacZ/+ gene trap mice (C), or N-cad-
herin+/+ (B) littermate controls and stained
with FDG to measure b-galactosidase activity
by flow cytometry. While most HSCs from
Rosa mice exhibited FDG staining (A), no
FDG staining was observed in HSCs from N-
cadherinlacZ/+ gene trap mice (C) above the
background observed in negative control
littermates (B) Flow cytometry plots depict
typical results from a single experiment, while
mean ± SD is presented for results from three
independent experiments.by flushing. Combining these statistics means that 98.5%
of all HSCs in the bone marrow were removed by flushing:
6750 ± 2280 HSCs were isolated from the long bones (two
femurs and two tibias) by flushing, and only an additional
106 ± 52 were recovered using the bone burr. This sug-
gests that significant numbers of HSCs are not left behind
when the marrow is carefully flushed out of the long bones.
To test whether the HSCs that were recovered using the
bone burr were functionally distinct from the HSCs iso-
lated by flushing, we performed competitive reconstitution
assays on 300,000 flushed or burred bone marrow cells.
Four of six recipients of burred bone marrow cells and
seven of seven recipients of flushed bone marrow cells
became long-term multilineage reconstituted by donor
cells (Figure 2F). There was no statistically significant dif-
ference between the levels of donor cells that arose from
flushed versus burred bone marrow cells (Figure 2F).
No Evidence for N-Cadherin Expression by HSCs
in Gene Trap Mice
We sought to confirm the lack of N-cadherin expression
by HSCs using an independent approach. N-cadherinlacZ
gene trap mice (Omnibank Sequence Tag OST 49160,
generated by Lexicon Genetics) have been generated by208 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Incretroviral insertion of lacZ into the first intron of N-cad-
herin, along with a strong splice acceptor sequence (Luo
et al., 2005). lacZ is expressed in these mice under the
control of the N-cadherin native promoter and other regu-
latory elements, allowing N-cadherin expression to be vi-
sualized based on b-galactosidase activity. b-galactosi-
dase expression in these mice matches the known
pattern of N-cadherin expression in the nervous system,
heart, somites, and limbs (Luo et al., 2005). Myocardium
sections from N-cadherinlacZ gene trap mice, but not litter-
mate controls, showed clear b-galactosidase activity
throughout the myocardium (see Figure S1 in the Supple-
mental Data available with this article online), as reported
previously (Luo et al., 2005). c-kit+Sca-1+lineageFlk-2
HSCs and CD150+CD48CD41c-kit+Sca-1+lineage
HSCs from Rosa mice (which ubiquitously express
b-galactosidase) showed b-galactosidase activity
(Figure 3A), but not HSCs from N-cadherinlacZ gene trap
mice (Figure 3C) or littermate controls (Figure 3B). Thus,
we were unable to detect N-cadherin expression by
HSCs in N-cadherinlacZ gene trap mice.
In case N-cadherin expression is induced by activation,
we also examined N-cadherin expression by HSCs in cul-
ture and after mobilization by cyclophosphamide/G-CSF..
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HSCs from Rosa mice and from N-cadherinlacZ gene
trap mice in liquid medium containing stem cell factor
(SCF), thrombopoietin, insulin-like growth factor II, and
acidic fibroblast growth factor (conditions that have been
found to promote the maintenance of HSCs in culture)
(Zhang and Lodish, 2005) for 4 days and then stained
with X-Gal. Cells cultured from Rosa mice exhibited clear
b-galactosidase activity, but not HSCs fromN-cadherinlacZ
gene trap mice or littermate controls (Figure S2A). We were
similarly unable to detect b-galactosidase expression by
CD150+CD48CD41c-kit+Sca-1+lineage HSCs from
the bone marrow or spleen of N-cadherinlacZ gene trap
mice or littermate controls that had been treated with cy-
clophosphamide/G-CSF, but we readily detected b-galac-
tosidase activity in HSCs from Rosa mice (Figure S2B).
Finally, we also failed to detect N-cadherin staining on
CD150+CD48CD41c-kit+Sca-1+lineage HSCs from
the spleen of cyclophosphamide/G-CSF-mobilized mice
using either the YS or GC-4 antibodies. Thus, we were un-
able to detect N-cadherin expression by cultured HSCs or
by mobilized HSCs.
N-Cadherin-Expressing Bone Marrow Cells
Do Not Have HSC Activity
Using the YS anti-N-cadherin antibody and the GC-4 anti-
N-cadherin antibody, we sorted bone marrow cells into N-
cadherin+ and N-cadherin fractions (Figure 4A), then
injected each fraction into irradiated mice in competitive
reconstitution assays. The doses of cells were initially
selected based on the fractions of N-cadherin+ and N-
cadherin bone marrow cells that were contained in
200,000 whole bone marrow cells, as has been done in
prior studies of marker expression by HSCs (Kiel et al.,
2005). For example, in one experiment, N-cadherin+
bone marrow cells that stained positively using the YS an-
tibody represented 2% of bone marrow cells. As a result,
we injected 4000 N-cadherin+ bone marrow cells or
196,000 N-cadherin bone marrow cells into irradiated
mice. Most (13/17) of the mice injected with N-cadherin
bone marrow cells became long-term multilineage recon-
stituted by donor cells, whereas none (0/17) of the mice in-
jected with N-cadherin+ cells became long-term multiline-
age reconstituted by donor cells (Figures 4A–4C). We
were thus unable to detect HSC activity among N-cad-
herin+ cells.
While this suggested that most HSCs were N-
cadherin, it left open the possibility that a minority of
HSCs were N-cadherin+ and that we did not inject enough
cells to detect this subset of HSCs. To address this, we
performed an independent experiment using the GC-4
antibody in which we injected the number of cells that
would be present in 300,000 bone marrow cells. In this ex-
periment, around 5% of bone marrow cells stained with
GC-4, so we injected 15,000 N-cadherin+ bone marrow
cells or 285,000 N-cadherin bone marrow cells into irra-
diated mice. To be certain that we did not miss any activity
in the N-cadherin+ fraction, we included a second group of
mice that was injected with 45,000 N-cadherin+ bone mar-Crow cells. Mice injected with N-cadherin bone marrow
cells always (12/12) became long-term multilineage re-
constituted by donor cells, whereas none (0/13) of the
mice injected with either dose of N-cadherin+ bone mar-
row cells became long-term multilineage reconstituted
by donor cells (Figures 4A–4C). We thus failed to detect
any HSC activity among N-cadherin+ bone marrow cells.
N-Cadherin-Expressing Bone Marrow Cells
Have Little Progenitor Activity in Culture
To test whether N-cadherin+ bone marrow cells have any
progenitor activity, we plated N-cadherin+ and N-
cadherin bone marrow cells in cytokine-supplemented
methylcellulose medium and assayed the colony-forming
ability of each fraction (Table 1). When highly purified
HSCs (such as CD150+CD48CD41c-kit+Sca-1+line-
age cells) are sorted into methylcellulose culture, more
than 90% of the single cells form colonies, and the vast
majority of the colonies are either CFU-GEMM (that con-
tain granulocytes, erythrocytes, macrophages, and mega-
karyocytes) or CFU-GM (that contain granulocytes and
macrophages) (Yilmaz et al., 2006b). Whether the YS or
the GC-4 anti-N-cadherin antibody was used to fraction-
ate bone marrow cells, virtually all colony-forming activity
was in the N-cadherin fraction of bone marrow cells,
including all CFU-GEMM and more than 99% of all CFU-
GM (Table 1). We also sorted N-cadherin+ and N-
cadherin bone marrow cells into methylcellulose based
on FDG staining of cells from N-cadherinlacZ gene trap
mice. Again, virtually all colony-forming activity was in
the N-cadherin fraction of bone marrow cells (Table 1).
N-cadherin+ bone marrow cells rarely formed colonies in
culture, particularly the types of colonies that are formed
by HSCs.
Osteoblast Depletion Does Not Necessarily Lead
to HSC Depletion
The foregoing data suggest that N-cadherin is unlikely to
act within HSCs to regulate their localization or function.
However, this does not address the role of osteoblasts
themselves in regulating bone marrow HSCs, as they
could still influence HSCs by other mechanisms. To better
understand the role that osteoblasts play in maintaining
HSCs, we tested whether there was a quantitative
relationship between osteoblast frequency and HSC fre-
quency in the bone marrow. We examined biglycan-
deficient mice to test whether depletion of osteoblasts
and osteoblast progenitors would reduce the number of
HSCs, as would be expected if osteoblasts are quantita-
tively required for HSC maintenance.
Biglycan is an extracellular matrix proteoglycan that is
most prominently expressed by osteoblasts and chondro-
cytes (Xu et al., 1998) (Figure S3A). biglycan-deficient
mice develop an osteoporosis-like phenotype, with less
trabecular bone, fewer osteoblasts, and fewer osteoblast
progenitors (Xu et al., 1998; Chen et al., 2002) (Figures
S3B–S3D). This is evident in 3-month-old mice but
worsens with age. We detected no statistically significant
differences among biglycan-deficient mice and littermateell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc. 209
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Hematopoietic Stem Cells Do Not Express N-CadherinFigure 4. All Detectable HSC Activity Is Contained within the N-Cadherin Fraction of Bone Marrow Cells
(A) Of bone marrow cells, 1.5%–6.8% stained positively for N-cadherin, depending on the antibody used (mean ± SD from three to eight independent
experiments). (B) Bone marrow cells were fractionated into N-cadherin and N-cadherin+ cells using either YS or GC-4 antibodies and injected into
lethally irradiated mice. Cell doses were based on the fraction of N-cadherin versus N-cadherin+ cells that were contained within 200,000 (YS) or
300,000 (GC-4) bone marrow cells as indicated in the table (C). To ensure that we did not miss infrequent N-cadherin+ HSCs, we also tripled the210 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc.
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Hematopoietic Stem Cells Do Not Express N-CadherinTable 1. The N-Cadherin+ Fraction of Bone Marrow Cells Has Little Capacity to Form Colonies in Culture and Lacks
the Ability to Form Primitive CFU-GEMM Colonies
Cells Added to
Culture
Percentage of
Cells that
Formed
Colonies
Percentage of All
Colonies that
Derived from This
Fraction
Percentage of All
CFU-GEMM that
Were in This
Fraction
Percentage of All
CFU-GM that
Were in This
Fraction
YS antibody N-cadherin+ 0.01% ± 0.02% 0.03% ± 0.08% 0% 0.05% ± 0.11%
N-cadherin 0.41% ± 0.08% 99.97% ± 0.08% 100% 99.95% ± 0.11%
GC-4 antibody N-cadherin+ 0.2% ± 0.2% 0.7% ± 0.4% 0% 0.8% ± 0.6%
N-cadherin 0.5% ± 0.03% 99.3% ± 0.4% 100% 99.2% ± 0.6%
N-cadherin+/+ FDG+ 0.53% ± 0.19% 1.4% ± 1.7% 0% 1.3% ± 1.5%
FDG 0.51% ± 0.02% 98.6% ± 1.7% 100% 98.7% ± 1.5%
N-cadherinlacZ FDG+ 0.56% ± 0.31% 2.4% ± 0.89% 0% 1.9% ± 0.7%
FDG 0.48% ± 0.04% 97.6% ± 0.89% 100% 98.1% ± 0.7%
N-cadherin+ or N-cadherin bone marrow cells were sorted based on staining with the YS polyclonal antibody or the GC-4 mono-
clonal antibody, or based on FDG staining for b-galactosidase activity in N-cadherin+/+ wild-type (control) mice or N-cadherinlacZ
gene trap mice. Cells were plated in methylcellulose medium supplemented with SCF, IL-3, IL-6, and erythropoietin. After 10–14
days, the number and type of colonies was counted. The data represent four to six independent experiments in which an average
of 16,000–17,500 N-cadherin bone marrow cells or 3000 to 5400 N-cadherin+ bone marrow cells were plated per experiment
(based on antibody staining) and two independent experiments in which 18,000–27,000 FDG bone marrow cells or 900 FDG+
bone marrow cells were plated per experiment. There was no statistically significant difference in the colonies formed by the
FDG+ fraction of cells from control wild-type mice as compared to N-cadherinlacZ gene trap mice, suggesting that the FDG staining
in rare colony-forming progenitors may be attributable to background. The three columns on the right side of the table show the
percentage of all CFU-C, CFU-GEMM, and CFU-GM from bone marrow that fall into the N-cadherin+ or N-cadherin fractions
of cells.controls of any age in the frequency of myeloid, erythroid,
B, or T lineage cells in the bone marrow (Figure S4A) or
spleen (Figure S4B). We also did not detect any differ-
ences in bone marrow cellularity (Figure 5A) or the number
(Figure 5B) or type (Figure 5C) of colony-forming progen-
itors in the bone marrow. The depletion of osteoblasts in
biglycan-deficient mice did not lead to discernable hema-
topoietic defects.
We also directly assayed HSC frequency and function in
these mice. We did not detect any differences among
biglycan-deficient mice and littermate controls at 3, 9–
15, or 24 months of age in the frequency (Figure 5D) or
absolute number (Figure 5E) of CD150+CD48CD41
c-kit+Sca-1+ HSCs in the bone marrow. To test HSC func-
tion, we transplanted 300,000 whole bone marrow cells
from 3-month-old biglycan-deficient mice or littermate
controls into 3- to 6-month-old biglycan-deficient or con-
trol recipients, along with 300,000 wild-type recipient
bone marrow cells for radioprotection. Donor mice in
these experiments were CD45.2+, while recipient mice
were CD45.1+, irrespective of genotype. The biglycan-
deficient bone marrow cells gave similar levels of long-
term multilineage reconstitution as wild-type donor cells,Cwhether they were transplanted into wild-type or bigly-
can-deficient recipients (Figure 5F). These data indicate
that biglycan deficiency had no effect on the level of re-
constituting activity in competitive reconstitution assays,
irrespective of whether the donors, the recipients, or
both were biglycan deficient. Thus, we detected no effect
of biglycan deficiency on HSC frequency or function.
HSCs in Wild-Type and biglycan-Deficient Bone
Marrow Localize Primarily to Sinusoids
Using methods described previously (Kiel et al., 2005), we
cut sections through the bone marrow of wild-type and
biglycan-deficient mice and stained with SLAM family
markers to localize HSCs. We observed no statistically
significant differences among wild-type and biglycan-
deficient mice in terms of the proportions of all bone
marrow cells that were adjacent to or within five cell diam-
eters of sinusoids or endosteum (Figure 6B). While not
statistically significant, biglycan-deficient mice tended to
have a lower proportion of bone marrow cells adjacent
to or within five cell diameters of endosteum (Figure 6B),
consistent with the reduced trabecular bone in these
mice (Figures S3B and S3C).dose of N-cadherin+ bone marrow cells that was transplanted in one experiment (C). Recipient mice were monitored for engraftment by donor my-
eloid, B, and T cells for 16 weeks after transplantation. Recipients of N-cadherin bone marrow cells almost always (YS) or always (GC-4) exhibited
high levels of long-term multilineage reconstitution by donor cells, while recipients of N-cadherin+ donor cells never exhibited long-term multilineage
reconstitution by donor cells. In (B), each line represents a single mouse, and the black line at 0.3% represents the level of background below which
donor cell engraftment could not be detected (shaded area). Data are from three to four independent experiments.ell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc. 211
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HSC Function despite Osteoblast Deple-
tion in the Absence of biglycan
(A) Slightly fewer bone marrow cells were re-
covered per femur and tibia of biglycan-defi-
cient (blue bars) mice as compared to litter-
mate controls (red bars) at 3, 9–15, or
24 months of age, though in no case was the
difference statistically significant (p = 0.09–
0.31; data from five independent experiments
with two to five mice per genotype per age).
Numbers (B) and types (C) of colonies that
formed in culture from biglycan-deficient (blue
bars) mice and littermate controls (red bars)
were similar at all ages. Frequency (D) and ab-
solute number (E) of CD150+CD48CD41c-
kit+Sca-1+ HSCs in bone marrow from control
littermates (Bgn+, red bars) and biglycan-defi-
cient (Bgn, blue bars) mice at 3, 9–15, or
24 months of age (p = 0.46–0.89). Data repre-
sent mean ± SD from two to five animals of
each genotype in one to three independent
experiments per age group. (F) HSC engraft-
ment and reconstitution in competitive repopu-
lation assays was not affected by biglycan
deficiency, irrespective of whether donors,
recipients, or both were biglycan deficient.
Bone marrow cells (300,000) from Bgn+ or
Bgn donors (along with 300,000 recipient
bone marrow cells) were transplanted into
Bgn+ or Bgn recipients. No statistically signif-
icant differences were detected in the level of
donor chimerism in any lineage in any treat-
ment. The data represent the results obtained
16 weeks after transplantation from one of
two independent experiments. A total of 12–
17 recipients were analyzed for each treatment
with two to three independent donors per
genotype. All error bars represent SD.Most bone marrow HSCs appeared to localize to sinu-
soids. CD150+CD48CD41lineage cells are very highly
enriched for HSCs (Kiel et al., 2005), and represented
0.0042%–0.0049% of cells in bone marrow sections in212 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inthese experiments (Figure 6C). In both wild-type and
biglycan-deficient mice, 58% of CD150+CD48CD41
lineage cells that we identified in sections were adjacent
to sinusoids, and almost all of these cells (92%–95%) werec.
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HSCs Mainly Localize to Sinusoids in
Wild-Type and biglycan-Deficient Mice
(A) Sections through the bone marrow of 9- to
15-month-old wild-type and biglycan-deficient
mice were analyzed by immunofluorescence
for the localization of CD150+CD48CD41
lineage HSCs. Slides were also stained with
an antibody against the panendothelial antigen
MECA-32 and the nuclear dye DAPI. The local-
ization of all bone marrow cells (B) and
CD150+CD48CD41lineage HSCs (C) was
assessed for proximity to MECA-32+ sinusoi-
dal endothelium or to endosteum. Arrow points
to a CD150+CD48CD41lineage cell adja-
cent to a MECA-32+ sinusoid (A). Data were
obtained from two to three mice per genotype
and represent mean ± SD.within five cell diameters of a sinusoid. This suggests that
HSCs are approximately 5-fold more likely than other
bone marrow cells to be adjacent to sinusoids, consistent
with our earlier observations (Kiel et al., 2005). Moreover,
the fact that nearly all HSCs are close to sinusoids sug-
gests that nearly all HSCs are likely to be influenced by
factors secreted by perivascular cells (Sugiyama et al.,
2006).
A smaller and potentially more variable proportion of
HSCs localized to the endosteum. In wild-type mice, we
did not detect any CD150+CD48CD41lineage cells at
the endosteum, while in biglycan-deficient mice, 4 of 19
(21%) CD150+CD48CD41lineage cells localized to
the endosteum. In our prior study (Kiel et al., 2005), we ob-
served 14% of wild-type CD150+CD48CD41lineage
cells localized to the endosteum. Thus, these results are
consistent with our earlier study in suggesting that a minor-
ity of bone marrow HSCs are present at the endosteum at
any point in time. We also did not detect many HSCs that
were within five cell diameters of the endosteum: only 8%–
21% of HSCs were visibly within five cell diameters of the
endosteum in these experiments. Nonetheless, this sug-
gests that HSCs are more likely than other bone marrow
cells to be close to the endosteum, even in mice in which
osteoblasts and trabecular bone have been depleted.CThese results are consistent with the possibility that the
endosteum may represent a niche for a subset of HSCs
despite the depletion of osteoblasts; however, most
HSCs either do not require contact with cells at the endos-
teum or require only intermittent contact.
DISCUSSION
A recent model of the HSC niche holds that HSCs adhere
to the surface of osteoblasts by N-cadherin-mediated
homophilic adhesion and that HSCs acutely depend
upon this interaction for their maintenance. But while this
model has received considerable attention, no study has
yet shown that N-cadherin-expressing bone marrow cells
have HSC activity or that N-cadherin is required by HSCs
for their maintenance.
When we examined N-cadherin expression in very
highly purified HSCs, we were unable to detect N-
cadherin expression by PCR (Figures 1A and 1B), by stain-
ing with the YS anti-N-cadherin antibody (Figure 1D),
by staining with the GC-4 anti-N-cadherin antibody
(Figure 1D), or by analyzing b-galactosidase expression
in N-cadherinlacZ gene trap mice (Figure 3C). This failure
to detect N-cadherin expression did not depend on the
use of SLAM family markers, as we were also unable toell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc. 213
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Flk-2 cells. These results are consistent with earlier re-
sults from us and others that failed to detect N-cadherin
expression by HSCs by microarray analysis (Ivanova
et al., 2002; Kiel et al., 2005).
Consistent with this, all of the HSC activity in long-term
reconstitution assays came from the N-cadherin fraction
of bone marrow cells, irrespective of whether we used the
YS or the GC-4 anti-N-cadherin antibodies (Figure 4). This
did not simply reflect an inability of N-cadherin+ bone mar-
row cells to engraft in vivo, as N-cadherin+ bone marrow
cells were rarely able to form primitive colonies in culture
(Table 1). We were thus unable to detect primitive progen-
itor activity from N-cadherin+ bone marrow cells in vitro or
in vivo. The only exception is that 3 of 30 irradiated mice
that were injected with N-cadherin+ bone marrow cells be-
came transiently multilineage reconstituted by low levels
of donor cells (Figures 4B and 4C). This raises the possibil-
ity that a small subset of transiently reconstituting multipo-
tent progenitors might express N-cadherin, though it is
also possible that N-cadherin cells contaminated the
N-cadherin+ fraction.
Although these data indicate that HSCs are unlikely to
be autonomously regulated by N-cadherin, it remains pos-
sible that osteoblasts play an important role in the mainte-
nance of bone marrow HSCs through other mechanisms.
But if HSCs do not adhere to the surface of osteoblasts
using N-cadherin, how do osteoblasts influence HSC
frequency?
A first step is to determine whether there is a quantitative
relationship between HSCs and osteoblasts in bone mar-
row. Although biglycan deficiency leads to progressive
osteoblast depletion with age (Xu et al., 1998), we did
not detect any effect of biglycan deficiency on hematopoi-
esis or on HSC frequency or function irrespective of age
(Figure 5). These data indicate there is not a quantitative
relationship between HSCs and osteoblasts in the bone
marrow: while modest increases in osteoblast numbers
modestly increase HSC numbers (Calvi et al., 2003; Zhang
et al., 2003), modest decreases in osteoblast numbers do
not necessarily decrease HSC numbers. Osteoblasts are
therefore not limiting for the creation of adult HSC niches.
Nonetheless, osteoblasts were never completely elimi-
nated from biglycan-deficient mice (Figure S3), so this
study does not suggest that these cells are not involved
in HSC maintenance.
We also confirmed our observation that approximately
60% of bone marrow CD150+CD48CD41lineage cells
localize to sinusoids at any one time (Figure 6). Moreover,
we extended this observation by finding that almost all
bone marrow CD150+CD48CD41lineage cells localize
within five cell diameters of sinusoids (Figure 6). This sug-
gests that almost all bone marrow HSCs are present in or
near perivascular environments. When combined with the
observation that perivascular reticular cells are a major
source of CXCL12, a factor that is required for HSC main-
tenance (Sugiyama et al., 2006); that endothelial cells can
promote the maintenance of HSCs in culture (Ohneda
et al., 1998; Li et al., 2004); and that endothelial cell func-214 Cell Stem Cell 1, 204–217, August 2007 ª2007 Elsevier Inc.tion is required for adult bone marrow hematopoiesis
in vivo (Yao et al., 2005), these data suggest that at least
some bone marrow HSCs are maintained in perivascular
niches.
A variety of other factors that regulate HSCs and hema-
topoiesis are also expressed around the vasculature in
bone marrow (Kopp et al., 2005). It is also possible that
mechanisms that have been suggested to regulate endos-
teal cells, such as sympathetic nervous system activity
(Katayama et al., 2006), also regulate perivascular cells.
Nonetheless, additional studies will be required to test
whether perivascular cells act directly on HSCs to pro-
mote their maintenance. It is also important to bear in
mind that some HSCs observed near sinusoids may be
migrating through these environments (Wright et al.,
2001) rather than being maintained there.
It was recently observed that most bone marrow HSCs
reside within relatively hypoxic environments (Parmar
et al., 2007). Although it has not yet been determined
which regions of the bone marrow are most hypoxic, it is
conceivable that sinusoids are among the most hypoxic
microenvironments. Sinusoids not only carry venous
circulation, but it is slow venous circulation that is not
designed to transport oxygen so much as to allow cells
to enter and exit circulation. In contrast, a rich supply of ar-
terial blood flows by and through the endosteum to nour-
ish bone. This issue will require additional studies.
While our data emphasize the potential role played by
perivascular cells in the regulation of HSCs, they do not
rule out a role for osteoblasts. We have observed a minor-
ity of CD150+CD48CD41lineage cells that localize to
the endosteum in this (Figure 6) and prior studies (Kiel
et al., 2005). However, these cells are considerably more
likely than other bone marrow cells to localize to the end-
osteum (Figure 6B versus Figure 6C). This is consistent
with the suggestion that a subset of HSCs localizes to
the endosteum (Nilsson et al., 2001; Zhang et al., 2003;
Arai et al., 2004; Kiel et al., 2005; Sugiyama et al., 2006;
Suzuki et al., 2006) and that osteoblasts and osteoclasts
may regulate the maintenance and migration of at least
some HSCs (Calvi et al., 2003; Zhang et al., 2003; Arai
et al., 2004; Adams et al., 2006; Kollet et al., 2006). None-
theless, our data suggest that osteoblasts are unlikely to
regulate HSCs by N-cadherin-mediated homophilic adhe-
sion. As with perivascular cells, in order to formally test
whether there is an endosteal niche for HSCs, it will be
necessary to test whether endosteal cells act directly on
HSCs to promote their maintenance through mechanisms
that are required in vivo.
Our demonstration that N-cadherin is not likely to regu-
late the adhesion of HSCs to osteoblasts, and the prior
demonstration that Notch1/Jagged1 interactions are not
required for HSC maintenance (Mancini et al., 2005),
means that all of the mechanisms by which endosteal cells
have been proposed to regulate HSCs involve secreted
factors. This raises a number of questions. First, do these
factors act directly on HSCs or do they act indirectly
through third-party cells? Endosteal cells may regulate
HSC maintenance primarily by recruiting other bone
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Barnstable, 2004), raising the possibility that osteoblasts
could promote HSC maintenance by recruiting vascular
niches. Second, if factors secreted from the endosteum
act directly on HSCs, do they act only on the subset of
HSCs that localizes to the endosteum or do they diffuse
to other microenvironments? Third, are the HSCs that lo-
calize near sinusoids different from the HSCs that localize
near the endosteum? So far there is no evidence for this,
as nearly all CD150+CD48CD41lineage cells are qui-
escent (Kiel et al., 2005) and there is no evidence for
a deeply quiescent subset of HSCs that goes months
without dividing (Cheshier et al., 1999). Nonetheless, it
remains possible that HSCs in different locations differ in
other ways. Finally, it would be interesting to be able to
test how often HSCs migrate between sinusoidal and end-
osteal environments.
Much remains to be learned regarding the identities of
the cells that contribute to the maintenance of HSCs and
the mechanisms by which they contribute. These mecha-
nisms will likely be complex, involving multiple cell types
and gene products, some of which act directly on HSCs
and others that act indirectly through third-party cells.
While the direct genetic experiments are conducted to
elucidate these mechanisms, it will be important for work-
ing models of HSC niches to acknowledge this potential
complexity.
EXPERIMENTAL PROCEDURES
Mice
C57BL/Ka-Thy-1.1 (Ly5.2) and C57BL/Ka-Thy-1.2 (Ly5.1) mice were
housed in the Unit for Laboratory Animal Medicine at the University
of Michigan. Adult mice were sacrificed between 8 and 10 weeks
of age unless otherwise stated. Neonatal mice were sacrificed
1–4 days after birth. Experiments to characterize hematopoiesis in
biglycan-deficient mice (an X-linked gene) were performed only on
males.
Flow Cytometry and the Isolation of HSCs
Bone marrow cells were flushed from the long bones (tibias and fe-
murs) with Hank’s buffered salt solution without calcium or magne-
sium, supplemented with 2% heat-inactivated calf serum (GIBCO,
Grand Island, NY; HBSS+). Cells were triturated and filtered through
nylon screen (45 mm, Sefar America, Kansas City, MO) to obtain a sin-
gle-cell suspension. For isolation of c-kit+Sca-1+lineage cells, whole
bone marrow cells were incubated with PE-conjugated monoclonal
antibodies to lineage markers including B220 (6B2), CD3 (KT31.1),
CD4 (GK1.5), CD8 (53-6.7), Gr-1 (8C5), Mac-1 (M1/70), Ter119, and
IgM in addition to FITC-conjugated anti-Sca-1 (Ly6A/E; E13-6.7) and
biotin-conjugated anti-c-kit (2B8). c-kit staining was visualized using
streptavidin APC-Cy7. Where indicated, an antibody against Flk-2
(A2F10.1) was used to isolate Flk-2 progenitors. For isolation of
CD150+CD48CD41c-kit+Sca-1+lineage HSCs, bone marrow cells
were incubated with PE-conjugated anti-CD150 (TC15-12F12.2; BioL-
egend, San Diego, CA), FITC-conjugated anti-CD48 (HM48-1; BioLe-
gend), FITC-conjugated anti-CD41 (MWReg30; BD PharMingen, San
Diego, CA), biotin-conjugated anti-Sca-1 (E13-6.7), and PE-Cy5-con-
jugated anti-c-kit (2B8) antibody, in addition to antibodies against the
following FITC-conjugated lineage markers: Ter119, B220 (6B2), Gr-1
(8C5), and CD2 (RM2-5). HSCs were sometimes pre-enriched by se-
lecting Sca-1+ or c-kit+ cells using paramagnetic microbeads and au-CtoMACS (Miltenyi Biotec, Auburn, CA). Nonviable cells were excluded
from sorts and analyses using the viability dye DAPI (1 mg/ml).
For isolation of bone marrow cells using the bone burr, bones were
flushed with HBSS+; then the lumen of bones was briefly drilled with
a high-speed microdrill using a 0.5 mm diameter steel bone burr
(Fine Science Tools, Foster City, CA). The bones were then eluted
a second time with HBSS+, triturated, and passed through a 27G nee-
dle several times prior to filtering through nylon mesh as above.
Methods for staining bone marrow sections for the localization of
HSCs are as described previously (Kiel et al., 2005). See the Supple-
mental Data for details. Methods for FDG staining of bone marrow
cells, quantitative PCR, and details regarding long-term competitive
reconstitution assays of irradiated mice are also present in the Supple-
mental Data.
N-Cadherin and Biglycan Antibody Staining
Cells were stained with antibodies against the extracellular domain of
N-cadherin (YS, IBL, Japan; GC-4, SIGMA, St. Louis, MO) at 1:50–
1:100 for 25 min on ice. Cells were then stained with APC or Cy5-
conjugated secondary antibodies (Jackson Immunoresearch, West
Grove, PA). Biglycan staining in sections was performed using a poly-
clonal antiserum provided by Dr. Larry Fisher (Bianco et al., 1990).
Methylcellulose Cultures
Sorted bone marrow cells were plated in wells of 96-well plates (Corn-
ing, Corning, NY) containing 100 ml 1.0% methylcellulose (Stem Cell
Technologies, Vancouver, BC) as previously described. The methyl-
cellulose was supplemented with 1% penicillin/streptomycin (GIBCO),
50 ng/ml SCF, 10 ng/ml interleukin-3 (IL-3), 10 ng/ml interleukin-6
(IL-6), and 3 U/ml erythropoietin (Epo). Colonies were maintained at
37C in humidified incubators at 6% O2. Colony formation was scored
after 10–14 days of culture.
Supplemental Data
Supplemental Data include four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with
this article online at http://www.cellstemcell.com/cgi/content/full/1/2/
204/DC1/.
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